FDA encourages industry to participate in Medical Device Single Audit Program (MDSAP)

Ronen E

Problem Solver
Staff member
Moderator
#1
From an FDA newsletter:

The Food and Drug Administration (FDA) joins the Medical Device Single Audit Program’s Regulatory Authority Council in encouraging medical device manufacturers to participate in the Medical Device Single Audit Program (MDSAP) Pilot. The Medical Device Single Audit Program is expected to begin transition to full implementation on January 1, 2017.

What is Medical Device Single Audit Program (MDSAP)?
As envisioned by the International Medical Device Regulators Forum (IMDRF), the FDA developed MDSAP in collaboration with regulatory authorities from Australia, Brazil, Canada, and Japan. IMDRF recognizes that a global approach to auditing and monitoring the manufacturing of medical devices could improve their safety and oversight on an international scale.

MDSAP enables medical device manufacturers to contract with an MDSAP-authorized Auditing Organization (AO) to conduct a single audit against the relevant medical device regulatory requirements of all fully participating regulatory authorities. For more information about the Medical Device Single Audit Program, please visit the FDA MDSAP Pilot Webpage.

In an effort to help inform the medical device manufacturing community about MDSAP, the FDA posted ten new medical device education modules to the CDRH Learn Program website.

What is CDRH Learn?
CDRH Learn is a multimedia catalog of online educational modules intended to provide information about medical device laws, regulations, and policies that is comprehensive, interactive, and easily accessible. The format for each topic is chosen to present the information in the most effective way possible.
 
Elsmar Forum Sponsor

Mark Meer

Trusted Information Resource
#2
Re: FDA encourages industry to participate in Medical Device Single Audit Program (MD

One way they could encourage participation is to lower the number of required audit hours.

As I've expressed in other threads, we got quotes from a few agencies, and all worked out to be approximately 3 times as expensive as maintaining our present ISO 13485 certification.

In principle, it seems like a good idea. But the added cost is a huge disincentive for companies to voluntarily enroll in the program...
 

Candi1024

Quite Involved in Discussions
#3
Re: FDA encourages industry to participate in Medical Device Single Audit Program (MD

I've also heard that under MDSAP rules, the FDA must be shown a full report of all audit findings if asked. Currently we are not required to show ISO13485 findings, only the certificate.

Does anyone know if this is true?
 

Mark Meer

Trusted Information Resource
#4
Re: FDA encourages industry to participate in Medical Device Single Audit Program (MD

I've also heard that under MDSAP rules, the FDA must be shown a full report of all audit findings if asked.
I also seem to recall talk of audit results being shared through an "MDSAP Portal" database, which will be shared amongst participating agencies (FDA, TGA, Health Canada,....).

This document seems to indicate that participating agencies will have access to the reports through such a database...

Also this article from LNE G-Med:
"After the MDSAP assessment the results (audit report) will be uploaded into a database that will be accessible by participating regulatory authorities."
 
Last edited:

DannyK

Trusted Information Resource
#5
Re: FDA encourages industry to participate in Medical Device Single Audit Program (MD

Small companies will see their audit costs rise.
I was at a conference with the FDA MDSAP representative and he said that the minimum time for a surveillance audit is 4 days.
There are many small or virtual manufacturers that will get out of CMDCAS because of the added costs. They usually have a 1 or 1.5 day surveillance audit.

Registrars will have to find extra resources to accommodate additional time and also to replace auditors who are doing consulting as well.

I am a CMDCAS lead assessor and will not be allowed to perform MDSAP audits since I am also a consultant.

I have no problem accepting this rule but I find it hard to believe that most of the companies will transfer from CMDCAS to MDSAP before January 1, 2019, which is the Health Canada deadline.
 

Ronen E

Problem Solver
Staff member
Moderator
#6
Re: FDA encourages industry to participate in Medical Device Single Audit Program (MD

I also seem to recall talk of audit results being shared through an "MDSAP Portal" database, which will be shared amongst participating agencies (FDA, TGA, Health Canada,....).

This document seems to indicate that participating agencies will have access to the reports through such a database...

Also this article from LNE G-Med:
"After the MDSAP assessment the results (audit report) will be uploaded into a database that will be accessible by participating regulatory authorities."
What's wrong with that? I thought that the whole idea was that you'd be audited once and that would serve for multiple regulatory domains / authorities. To me it seems natural that an authority granting clearance would have access to the information that allows such clearance.

Would it be better to be actually audited by each one of these authorities, instead?

The only manufacturers to gain from lack of transparency are the ones that have something to hide. Isn't it so?
 

Mark Meer

Trusted Information Resource
#7
Re: FDA encourages industry to participate in Medical Device Single Audit Program (MD

What's wrong with that?
Where did you get the impression I was insinuating there was anything wrong with this?

As I've expressed, my biggest gripe is simply the huge added financial burden...
 

Chrisx

Involved In Discussions
#8
Re: FDA encourages industry to participate in Medical Device Single Audit Program (MD

If you previously participated in the voluntary ISO 13485 submission process, you had to submit your audit report to FDA. In this regards, MDSAP is no different. FDA never accepted just submitting an ISO 13485 certificate.

I actually agree with FDA that audit duration according to IAF is not long enough, especially considering additional time is needed to cover the regulatory requirements of the CFRs. It will all depend upon whether companies feel the extra cost is worth avoiding an FDA inspection. For sure, we would have been inspected by FDA long ago, if we hadn't participated in the voluntary ISO 13485 submission process. The district office even cancelled one inspection after we informed them that we were a participant and had been taken off the routine inspection schedule for 1-year.

Unfortunately without the threat of FDA inspection, compliance has become less of a priority for my employer. Perhaps the additional time of an MDSAP inspection will force some changes.
 

Mark Meer

Trusted Information Resource
#9
Re: FDA encourages industry to participate in Medical Device Single Audit Program (MD

I actually agree with FDA that audit duration according to IAF is not long enough, especially considering additional time is needed to cover the regulatory requirements of the CFRs.
I can't help but feel the FDA's audit duration calculation could be use some work.

The procedure assigns specific times for audit task, but does not seem to consider things such as:

  • How efficiently is the system organized? Should the task time be the same for a paper-based system (where it can take minutes to dig up a particular referenced record) versus an electronic system (where records can be retrieved immediately)?
  • How complicated is each process? Should the task time be the same for a company with a complicated device, with a tonne of suppliers and intricate manufacturing process, versus a simple device whose manufacturing process is straight-forward?
  • How many records are there? Should the task time be the same for a company that has received 2 complaints in the past year versus one that has received 200?

To assign task-based times, in my opinion, is to penalize those companies that run efficient/simple/small systems, because the auditors will end up either scrutinizing more, or finish faster yet bill for the same number of hours.
 

Ronen E

Problem Solver
Staff member
Moderator
#10
Re: FDA encourages industry to participate in Medical Device Single Audit Program (MD

Where did you get the impression I was insinuating there was anything wrong with this?

As I've expressed, my biggest gripe is simply the huge added financial burden...
Very well, so we think along similar lines. :agree:
 
Thread starter Similar threads Forum Replies Date
M Medical Device News FDA News - 07-09-18 - FDA Encourages Use of Enteral Device Connectors Other US Medical Device Regulations 0
J Is Device Tracking Card an actual requirement under FDA regulation? Other US Medical Device Regulations 0
T Definition Human Use (FDA) Definitions, Acronyms, Abbreviations and Interpretations Listed Alphabetically 7
K FDA 510k electrosurgery 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 0
J Leveraging FDA 510k Clearance for International Registrations Other Medical Device Regulations World-Wide 2
shimonv FDA News FDA guidance on Multiple Function Device Products (8/2020) Other US Medical Device Regulations 1
N FDA UDI - Label vs. Labeling - Does the insert need to include UDI? Other US Medical Device Regulations 0
J FDA notification of address change US Food and Drug Administration (FDA) 2
N Usability testing required for FDA IDE (investigational device exemption)? Human Factors and Ergonomics in Engineering 3
A FDA Class Classification for a cabinet 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
L FDA Biocompatibility Requirements - Transitory Contact Other US Medical Device Regulations 1
Edward Reesor FDA DM and /or Class I Life Saving US Food and Drug Administration (FDA) 0
Watchcat FDA will not tolerate fraud…meaning what, exactly? Other US Medical Device Regulations 6
K FDA Premarket Cybersecurity Guidance - 4 questions Other US Medical Device Regulations 5
gunnyshore Form FDA 3500A MedWatch eSubmitter 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 5
Watchcat FDA Webinar Series - N95 Respirators Other US Medical Device Regulations 0
M Off-Label Use - Clarification of FDA Policy US Food and Drug Administration (FDA) 1
J Sub-supplier change from manual to automated process - same specs - Report to FDA? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
C FDA Establishment registration - Buying some medical devices from another manufacturer Medical Device and FDA Regulations and Standards News 5
I How to classify a medical device based on FDA? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 3
dinaroxentool Question about FDA Classification of a Device 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 3
S The US FDA requirements on Disposal of a medical device US Food and Drug Administration (FDA) 1
S FDA Requirements for Medical Device Label Reconciliation 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
S What is considered a "core algorithm"? (From an FDA guidance document) Medical Information Technology, Medical Software and Health Informatics 4
B FDA-Medical Device Reporting (MDR )procedure compliant with 21CFR section 803 US Food and Drug Administration (FDA) 0
Stoic Are any medical device companies using the 2011 FDA process validation guidance instead of GHTF/SG3/N99-10:2004? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
D ISO 13485, FDA 21 CFR 820 and Auditing the Accounting Department ISO 13485:2016 - Medical Device Quality Management Systems 5
S FDA's E submitter - For clinical electronic thermometer Medical Device and FDA Regulations and Standards News 6
J FDA wants electrical safety testing on battery powered medical device US Food and Drug Administration (FDA) 11
A FDA and NB audit of Engineering Drawings in DHF and DMR. Medical Device and FDA Regulations and Standards News 1
D FDA De Novo Cover Letter - What is expected US Food and Drug Administration (FDA) 3
Ed Panek 21 CFR Part 820 - FDA Label Requirements 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 8
J Mislabeling - Consider this an FDA notified recall? CFR 806.10 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
O Hospital-Developed, In-House Device - FDA Clearance? Other US Medical Device Regulations 19
D FDA Approved Class II Medical Device? Other US Medical Device Regulations 11
R When does the FDA consider a component a medical device? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 17
N Risk Management besides mandated FDA requirements 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
M Informational US FDA – Ear, Nose, and Throat Devices; Classification of the Self-Fitting Air-Conduction Hearing Aid Medical Device and FDA Regulations and Standards News 0
L UDI Requirments Gap Analysis - EU MDR vs FDA CFR EU Medical Device Regulations 8
M Informational US FDA – Modifications to the List of Recognized Standards, Recognition List Number: 052 Medical Device and FDA Regulations and Standards News 0
M Informational US FDA Draft Guidance – Breast Implants – Certain Labeling Recommendations to Improve Patient Communication Medical Device and FDA Regulations and Standards News 0
M Looking for third party reviewers for FDA submissions US Food and Drug Administration (FDA) 2
M Informational Work in progress at the FDA for biological evaluation – Color Hazard and RISk calculator (CHRIS) Medical Device and FDA Regulations and Standards News 0
M Informational US FDA – CDRH Proposed Guidances for Fiscal Year 2020 (FY 2020) Medical Device and FDA Regulations and Standards News 0
M Informational US FDA Final Guidance – Coronary, Peripheral, and Neurovascular Guidewires – Performance Tests and Recommended Labeling Medical Device and FDA Regulations and Standards News 0
M Informational US FDA Final Guidance – Intravascular Catheters, Wires, and Delivery Systems with Lubricious Coatings – Labeling Considerations Medical Device and FDA Regulations and Standards News 0
T Clinical trial - Medical device product not cleared (without FDA approval) in a drug trial Other US Medical Device Regulations 9
William55401 How Often Does FDA State Consultant Recommended in a Pharma WL? US Food and Drug Administration (FDA) 1
M Informational US FDA – URGENT/11 Cybersecurity Vulnerabilities in a Widely-Used Third-Party Software Component May Introduce Risks During Use of Certain Medical Dev Medical Device and FDA Regulations and Standards News 0
M Informational US FDA paper – Epidemiological Evidence on the Adverse Health Effects Reports in Relation to Mercury from Dental Amalgam: Systematic Literature Review Medical Device and FDA Regulations and Standards News 0

Similar threads

Top Bottom